Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis

Autores
Efe, Cumali; Lammert, Craig; Taşçılar, Koray; Dhanasekaran, Renumathy; Ebik, Berat; Higuera de la Tijera, Fatima; Calışkan, Ali R.; Peralta, Mirta; Gerussi, Alessio; Massoumi, Hatef; Catana, Andreea M.; Purnak, Tugrul; Rigamonti, Cristina; Aldana, Andres J. G.; Khakoo, Nidah; Nazal, Leyla; Frager, Shalom; Demir, Nurhan; Irak, Kader; Melekoğlu Ellik, Zeynep; Kacmaz, Hüseyin; Balaban, Yasemin; Atay, Kadri; Eren, Fatih; Alvares da-Silva, Mario R.; Cristoferi, Laura; Urzua, Álvaro; Eşkazan, Tuğçe; Magro, Bianca; Snijders, Romee; Barutçu, Sezgin; Lytvyak, Ellina; Zazueta, Godolfino M.; Demirezer Bolat, Aylin; Aydın, Mesut; Amorós Martín, Alexandra Noemí; De Martin, Eleonora; Ekin, Nazım; Yıldırım, Sümeyra; Yavuz, Ahmet; Bıyık, Murat; Narro, Graciela C.; Bıyık, Murat; Kıyıcı, Murat; Kahramanoğlu Aksoy, Evrim; Vincent, Maria; Carr, Rotonya M.; Günşar, Fulya; Reyes, Eira C.; Harputluoğlu, Murat; Aloman, Costica; Gatselis, Nikolaos K.; Üstündağ, Yücel; Brahm, Javier; Vargas, Nataly C. E.; Güzelbulut, Fatih; Garcia, Sandro R.; Aguirre, Jonathan; Anders, Margarita; Ratusnu, Natalia; Hatemi, Ibrahim; Mendizabal, Manuel; Floreani, Annarosa; Fagiuoli, Stefano; Silva, Marcelo; Idilman, Ramazan; Satapathy, Sanjaya K.; Silveira, Marina; Drenth, Joost P. H.; Dalekos, George N.; N.Assis, David; Björnsson, Einar; Boyer, James L.; Yoshida, Eric M.; Invernizzi, Pietro; Levy, Cynthia; Montano Loza, Aldo J.; Schiano, Thomas D.; Ridruejo, Ezequiel; Wahlin, Staffan
Año de publicación
2021
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes of AIH patients who were on immunosuppression at the time of COVID-19 were compared to patients who were not on AIH medication. The clinical courses of COVID-19 were classified as (i)-no hospitalization, (ii)-hospitalization without oxygen supplementation, (iii)-hospitalization with oxygen supplementation by nasal cannula or mask, (iv)-intensive care unit (ICU) admission with non-invasive mechanical ventilation, (v)-ICU admission with invasive mechanical ventilation or (vi)-death and analysed using ordinal logistic regression. Results: We included 254 AIH patients (79.5%, female) with a median age of 50 (range, 17-85) years. At the onset of COVID-19, 234 patients (92.1%) were on treatment with glucocorticoids (n = 156), thiopurines (n = 151), mycophenolate mofetil (n = 22) or tacrolimus (n = 16), alone or in combinations. Overall, 94 (37%) patients were hospitalized and 18 (7.1%) patients died. Use of systemic glucocorticoids (adjusted odds ratio [aOR] 4.73, 95% CI 1.12-25.89) and thiopurines (aOR 4.78, 95% CI 1.33-23.50) for AIH was associated with worse COVID-19 severity, after adjusting for age-sex, comorbidities and presence of cirrhosis. Baseline treatment with mycophenolate mofetil (aOR 3.56, 95% CI 0.76-20.56) and tacrolimus (aOR 4.09, 95% CI 0.69-27.00) were also associated with more severe COVID-19 courses in a smaller subset of treated patients. Conclusion: Baseline treatment with systemic glucocorticoids or thiopurines prior to the onset of COVID-19 was significantly associated with COVID-19 severity in patients with AIH.
Fil: Efe, Cumali. Harran University Hospita; Turquía
Fil: Lammert, Craig. University School of Medicine Indianapolis; Estados Unidos
Fil: Taşçılar, Koray. Universitat Erlangen-Nuremberg; Alemania
Fil: Dhanasekaran, Renumathy. University of Stanford; Estados Unidos
Fil: Ebik, Berat. Gazi Yasargil Education And Research Hospital; Turquía
Fil: Higuera de la Tijera, Fatima. Hospital General de México; México
Fil: Calışkan, Ali R.. No especifíca;
Fil: Peralta, Mirta. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas "Dr. Francisco Javier Muñiz"; Argentina
Fil: Gerussi, Alessio. Università degli Studi di Milano; Italia
Fil: Massoumi, Hatef. No especifíca;
Fil: Catana, Andreea M.. Harvard Medical School; Estados Unidos
Fil: Purnak, Tugrul. University of Texas; Estados Unidos
Fil: Rigamonti, Cristina. Università del Piemonte Orientale ; Italia
Fil: Aldana, Andres J. G.. Fundacion Santa Fe de Bogota; Colombia
Fil: Khakoo, Nidah. Miami University; Estados Unidos
Fil: Nazal, Leyla. Clinica Las Condes; Chile
Fil: Frager, Shalom. Montefiore Medical Center; Estados Unidos
Fil: Demir, Nurhan. Haseki Training And Research Hospital; Turquía
Fil: Irak, Kader. Kanuni Sultan Suleyman Training And Research Hospital; Turquía
Fil: Melekoğlu Ellik, Zeynep. Ankara University Medical Faculty; Turquía
Fil: Kacmaz, Hüseyin. Adıyaman University; Turquía
Fil: Balaban, Yasemin. Hacettepe University; Turquía
Fil: Atay, Kadri. No especifíca;
Fil: Eren, Fatih. No especifíca;
Fil: Alvares da-Silva, Mario R.. Universidade Federal do Rio Grande do Sul; Brasil
Fil: Cristoferi, Laura. Università degli Studi di Milano; Italia
Fil: Urzua, Álvaro. Universidad de Chile; Chile
Fil: Eşkazan, Tuğçe. Cerrahpaşa School of Medicine; Turquía
Fil: Magro, Bianca. No especifíca;
Fil: Snijders, Romee. No especifíca;
Fil: Barutçu, Sezgin. No especifíca;
Fil: Lytvyak, Ellina. University of Alberta; Canadá
Fil: Zazueta, Godolfino M.. Instituto Nacional de la Nutrición Salvador Zubiran; México
Fil: Demirezer Bolat, Aylin. Ankara City Hospital; Turquía
Fil: Aydın, Mesut. Van Yuzuncu Yil University; Turquía
Fil: Amorós Martín, Alexandra Noemí. No especifíca;
Fil: De Martin, Eleonora. No especifíca;
Fil: Ekin, Nazım. No especifíca;
Fil: Yıldırım, Sümeyra. No especifíca;
Fil: Yavuz, Ahmet. No especifíca;
Fil: Bıyık, Murat. Necmettin Erbakan University; Turquía
Fil: Narro, Graciela C.. Instituto Nacional de la Nutrición Salvador Zubiran; México
Fil: Bıyık, Murat. Uludag University; Turquía
Fil: Kıyıcı, Murat. No especifíca;
Fil: Kahramanoğlu Aksoy, Evrim. No especifíca;
Fil: Vincent, Maria. No especifíca;
Fil: Carr, Rotonya M.. University of Pennsylvania; Estados Unidos
Fil: Günşar, Fulya. No especifíca;
Fil: Reyes, Eira C.. Hepatology Unit. Hospital Militar Central de México; México
Fil: Harputluoğlu, Murat. Inönü University School of Medicine; Turquía
Fil: Aloman, Costica. Rush University Medical Center; Estados Unidos
Fil: Gatselis, Nikolaos K.. University Hospital Of Larissa; Grecia
Fil: Üstündağ, Yücel. No especifíca;
Fil: Brahm, Javier. Clinica Las Condes; Chile
Fil: Vargas, Nataly C. E.. Hospital Nacional Almanzor Aguinaga Asenjo; Perú
Fil: Güzelbulut, Fatih. No especifíca;
Fil: Garcia, Sandro R.. Hospital Iv Víctor Lazarte Echegaray; Perú
Fil: Aguirre, Jonathan. Hospital Angeles del Pedregal; México
Fil: Anders, Margarita. Hospital Alemán; Argentina
Fil: Ratusnu, Natalia. Hospital Regional de Ushuaia; Argentina
Fil: Hatemi, Ibrahim. No especifíca;
Fil: Mendizabal, Manuel. Universidad Austral; Argentina
Fil: Floreani, Annarosa. Università di Padova; Italia
Fil: Fagiuoli, Stefano. No especifíca;
Fil: Silva, Marcelo. Universidad Austral; Argentina
Fil: Idilman, Ramazan. No especifíca;
Fil: Satapathy, Sanjaya K.. No especifíca;
Fil: Silveira, Marina. University of Yale. School of Medicine; Estados Unidos
Fil: Drenth, Joost P. H.. No especifíca;
Fil: Dalekos, George N.. No especifíca;
Fil: N.Assis, David. University of Yale. School of Medicine; Estados Unidos
Fil: Björnsson, Einar. No especifíca;
Fil: Boyer, James L.. University of Yale. School of Medicine; Estados Unidos
Fil: Yoshida, Eric M.. University of British Columbia; Canadá
Fil: Invernizzi, Pietro. Università degli Studi di Milano; Italia
Fil: Levy, Cynthia. University of Miami; Estados Unidos
Fil: Montano Loza, Aldo J.. University of Alberta; Canadá
Fil: Schiano, Thomas D.. No especifíca;
Fil: Ridruejo, Ezequiel. Universidad Austral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; Argentina
Fil: Wahlin, Staffan. No especifíca;
Materia
AUTOIMMUNITY
AZATHIOPRINE
BUDESONIDE
LIVER TRANSPLANTATION
MERCAPTOPURINE
SARS-COV-2
COVID-19
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/172868

id CONICETDig_47b0889836de89c6b677de77a529f218
oai_identifier_str oai:ri.conicet.gov.ar:11336/172868
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitisEfe, CumaliLammert, CraigTaşçılar, KorayDhanasekaran, RenumathyEbik, BeratHiguera de la Tijera, FatimaCalışkan, Ali R.Peralta, MirtaGerussi, AlessioMassoumi, HatefCatana, Andreea M.Purnak, TugrulRigamonti, CristinaAldana, Andres J. G.Khakoo, NidahNazal, LeylaFrager, ShalomDemir, NurhanIrak, KaderMelekoğlu Ellik, ZeynepKacmaz, HüseyinBalaban, YaseminAtay, KadriEren, FatihAlvares da-Silva, Mario R.Cristoferi, LauraUrzua, ÁlvaroEşkazan, TuğçeMagro, BiancaSnijders, RomeeBarutçu, SezginLytvyak, EllinaZazueta, Godolfino M.Demirezer Bolat, AylinAydın, MesutAmorós Martín, Alexandra NoemíDe Martin, EleonoraEkin, NazımYıldırım, SümeyraYavuz, AhmetBıyık, MuratNarro, Graciela C.Bıyık, MuratKıyıcı, MuratKahramanoğlu Aksoy, EvrimVincent, MariaCarr, Rotonya M.Günşar, FulyaReyes, Eira C.Harputluoğlu, MuratAloman, CosticaGatselis, Nikolaos K.Üstündağ, YücelBrahm, JavierVargas, Nataly C. E.Güzelbulut, FatihGarcia, Sandro R.Aguirre, JonathanAnders, MargaritaRatusnu, NataliaHatemi, IbrahimMendizabal, ManuelFloreani, AnnarosaFagiuoli, StefanoSilva, MarceloIdilman, RamazanSatapathy, Sanjaya K.Silveira, MarinaDrenth, Joost P. H.Dalekos, George N.N.Assis, DavidBjörnsson, EinarBoyer, James L.Yoshida, Eric M.Invernizzi, PietroLevy, CynthiaMontano Loza, Aldo J.Schiano, Thomas D.Ridruejo, EzequielWahlin, StaffanAUTOIMMUNITYAZATHIOPRINEBUDESONIDELIVER TRANSPLANTATIONMERCAPTOPURINESARS-COV-2COVID-19https://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes of AIH patients who were on immunosuppression at the time of COVID-19 were compared to patients who were not on AIH medication. The clinical courses of COVID-19 were classified as (i)-no hospitalization, (ii)-hospitalization without oxygen supplementation, (iii)-hospitalization with oxygen supplementation by nasal cannula or mask, (iv)-intensive care unit (ICU) admission with non-invasive mechanical ventilation, (v)-ICU admission with invasive mechanical ventilation or (vi)-death and analysed using ordinal logistic regression. Results: We included 254 AIH patients (79.5%, female) with a median age of 50 (range, 17-85) years. At the onset of COVID-19, 234 patients (92.1%) were on treatment with glucocorticoids (n = 156), thiopurines (n = 151), mycophenolate mofetil (n = 22) or tacrolimus (n = 16), alone or in combinations. Overall, 94 (37%) patients were hospitalized and 18 (7.1%) patients died. Use of systemic glucocorticoids (adjusted odds ratio [aOR] 4.73, 95% CI 1.12-25.89) and thiopurines (aOR 4.78, 95% CI 1.33-23.50) for AIH was associated with worse COVID-19 severity, after adjusting for age-sex, comorbidities and presence of cirrhosis. Baseline treatment with mycophenolate mofetil (aOR 3.56, 95% CI 0.76-20.56) and tacrolimus (aOR 4.09, 95% CI 0.69-27.00) were also associated with more severe COVID-19 courses in a smaller subset of treated patients. Conclusion: Baseline treatment with systemic glucocorticoids or thiopurines prior to the onset of COVID-19 was significantly associated with COVID-19 severity in patients with AIH.Fil: Efe, Cumali. Harran University Hospita; TurquíaFil: Lammert, Craig. University School of Medicine Indianapolis; Estados UnidosFil: Taşçılar, Koray. Universitat Erlangen-Nuremberg; AlemaniaFil: Dhanasekaran, Renumathy. University of Stanford; Estados UnidosFil: Ebik, Berat. Gazi Yasargil Education And Research Hospital; TurquíaFil: Higuera de la Tijera, Fatima. Hospital General de México; MéxicoFil: Calışkan, Ali R.. No especifíca;Fil: Peralta, Mirta. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas "Dr. Francisco Javier Muñiz"; ArgentinaFil: Gerussi, Alessio. Università degli Studi di Milano; ItaliaFil: Massoumi, Hatef. No especifíca;Fil: Catana, Andreea M.. Harvard Medical School; Estados UnidosFil: Purnak, Tugrul. University of Texas; Estados UnidosFil: Rigamonti, Cristina. Università del Piemonte Orientale ; ItaliaFil: Aldana, Andres J. G.. Fundacion Santa Fe de Bogota; ColombiaFil: Khakoo, Nidah. Miami University; Estados UnidosFil: Nazal, Leyla. Clinica Las Condes; ChileFil: Frager, Shalom. Montefiore Medical Center; Estados UnidosFil: Demir, Nurhan. Haseki Training And Research Hospital; TurquíaFil: Irak, Kader. Kanuni Sultan Suleyman Training And Research Hospital; TurquíaFil: Melekoğlu Ellik, Zeynep. Ankara University Medical Faculty; TurquíaFil: Kacmaz, Hüseyin. Adıyaman University; TurquíaFil: Balaban, Yasemin. Hacettepe University; TurquíaFil: Atay, Kadri. No especifíca;Fil: Eren, Fatih. No especifíca;Fil: Alvares da-Silva, Mario R.. Universidade Federal do Rio Grande do Sul; BrasilFil: Cristoferi, Laura. Università degli Studi di Milano; ItaliaFil: Urzua, Álvaro. Universidad de Chile; ChileFil: Eşkazan, Tuğçe. Cerrahpaşa School of Medicine; TurquíaFil: Magro, Bianca. No especifíca;Fil: Snijders, Romee. No especifíca;Fil: Barutçu, Sezgin. No especifíca;Fil: Lytvyak, Ellina. University of Alberta; CanadáFil: Zazueta, Godolfino M.. Instituto Nacional de la Nutrición Salvador Zubiran; MéxicoFil: Demirezer Bolat, Aylin. Ankara City Hospital; TurquíaFil: Aydın, Mesut. Van Yuzuncu Yil University; TurquíaFil: Amorós Martín, Alexandra Noemí. No especifíca;Fil: De Martin, Eleonora. No especifíca;Fil: Ekin, Nazım. No especifíca;Fil: Yıldırım, Sümeyra. No especifíca;Fil: Yavuz, Ahmet. No especifíca;Fil: Bıyık, Murat. Necmettin Erbakan University; TurquíaFil: Narro, Graciela C.. Instituto Nacional de la Nutrición Salvador Zubiran; MéxicoFil: Bıyık, Murat. Uludag University; TurquíaFil: Kıyıcı, Murat. No especifíca;Fil: Kahramanoğlu Aksoy, Evrim. No especifíca;Fil: Vincent, Maria. No especifíca;Fil: Carr, Rotonya M.. University of Pennsylvania; Estados UnidosFil: Günşar, Fulya. No especifíca;Fil: Reyes, Eira C.. Hepatology Unit. Hospital Militar Central de México; MéxicoFil: Harputluoğlu, Murat. Inönü University School of Medicine; TurquíaFil: Aloman, Costica. Rush University Medical Center; Estados UnidosFil: Gatselis, Nikolaos K.. University Hospital Of Larissa; GreciaFil: Üstündağ, Yücel. No especifíca;Fil: Brahm, Javier. Clinica Las Condes; ChileFil: Vargas, Nataly C. E.. Hospital Nacional Almanzor Aguinaga Asenjo; PerúFil: Güzelbulut, Fatih. No especifíca;Fil: Garcia, Sandro R.. Hospital Iv Víctor Lazarte Echegaray; PerúFil: Aguirre, Jonathan. Hospital Angeles del Pedregal; MéxicoFil: Anders, Margarita. Hospital Alemán; ArgentinaFil: Ratusnu, Natalia. Hospital Regional de Ushuaia; ArgentinaFil: Hatemi, Ibrahim. No especifíca;Fil: Mendizabal, Manuel. Universidad Austral; ArgentinaFil: Floreani, Annarosa. Università di Padova; ItaliaFil: Fagiuoli, Stefano. No especifíca;Fil: Silva, Marcelo. Universidad Austral; ArgentinaFil: Idilman, Ramazan. No especifíca;Fil: Satapathy, Sanjaya K.. No especifíca;Fil: Silveira, Marina. University of Yale. School of Medicine; Estados UnidosFil: Drenth, Joost P. H.. No especifíca;Fil: Dalekos, George N.. No especifíca;Fil: N.Assis, David. University of Yale. School of Medicine; Estados UnidosFil: Björnsson, Einar. No especifíca;Fil: Boyer, James L.. University of Yale. School of Medicine; Estados UnidosFil: Yoshida, Eric M.. University of British Columbia; CanadáFil: Invernizzi, Pietro. Università degli Studi di Milano; ItaliaFil: Levy, Cynthia. University of Miami; Estados UnidosFil: Montano Loza, Aldo J.. University of Alberta; CanadáFil: Schiano, Thomas D.. No especifíca;Fil: Ridruejo, Ezequiel. Universidad Austral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; ArgentinaFil: Wahlin, Staffan. No especifíca;Wiley Blackwell Publishing, Inc2021-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/172868Efe, Cumali; Lammert, Craig; Taşçılar, Koray; Dhanasekaran, Renumathy; Ebik, Berat; et al.; Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis; Wiley Blackwell Publishing, Inc; Liver International; 42; 3; 11-2021; 607-6141478-3223CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1111/liv.15121info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:36:05Zoai:ri.conicet.gov.ar:11336/172868instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:36:05.269CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
title Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
spellingShingle Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
Efe, Cumali
AUTOIMMUNITY
AZATHIOPRINE
BUDESONIDE
LIVER TRANSPLANTATION
MERCAPTOPURINE
SARS-COV-2
COVID-19
title_short Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
title_full Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
title_fullStr Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
title_full_unstemmed Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
title_sort Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis
dc.creator.none.fl_str_mv Efe, Cumali
Lammert, Craig
Taşçılar, Koray
Dhanasekaran, Renumathy
Ebik, Berat
Higuera de la Tijera, Fatima
Calışkan, Ali R.
Peralta, Mirta
Gerussi, Alessio
Massoumi, Hatef
Catana, Andreea M.
Purnak, Tugrul
Rigamonti, Cristina
Aldana, Andres J. G.
Khakoo, Nidah
Nazal, Leyla
Frager, Shalom
Demir, Nurhan
Irak, Kader
Melekoğlu Ellik, Zeynep
Kacmaz, Hüseyin
Balaban, Yasemin
Atay, Kadri
Eren, Fatih
Alvares da-Silva, Mario R.
Cristoferi, Laura
Urzua, Álvaro
Eşkazan, Tuğçe
Magro, Bianca
Snijders, Romee
Barutçu, Sezgin
Lytvyak, Ellina
Zazueta, Godolfino M.
Demirezer Bolat, Aylin
Aydın, Mesut
Amorós Martín, Alexandra Noemí
De Martin, Eleonora
Ekin, Nazım
Yıldırım, Sümeyra
Yavuz, Ahmet
Bıyık, Murat
Narro, Graciela C.
Bıyık, Murat
Kıyıcı, Murat
Kahramanoğlu Aksoy, Evrim
Vincent, Maria
Carr, Rotonya M.
Günşar, Fulya
Reyes, Eira C.
Harputluoğlu, Murat
Aloman, Costica
Gatselis, Nikolaos K.
Üstündağ, Yücel
Brahm, Javier
Vargas, Nataly C. E.
Güzelbulut, Fatih
Garcia, Sandro R.
Aguirre, Jonathan
Anders, Margarita
Ratusnu, Natalia
Hatemi, Ibrahim
Mendizabal, Manuel
Floreani, Annarosa
Fagiuoli, Stefano
Silva, Marcelo
Idilman, Ramazan
Satapathy, Sanjaya K.
Silveira, Marina
Drenth, Joost P. H.
Dalekos, George N.
N.Assis, David
Björnsson, Einar
Boyer, James L.
Yoshida, Eric M.
Invernizzi, Pietro
Levy, Cynthia
Montano Loza, Aldo J.
Schiano, Thomas D.
Ridruejo, Ezequiel
Wahlin, Staffan
author Efe, Cumali
author_facet Efe, Cumali
Lammert, Craig
Taşçılar, Koray
Dhanasekaran, Renumathy
Ebik, Berat
Higuera de la Tijera, Fatima
Calışkan, Ali R.
Peralta, Mirta
Gerussi, Alessio
Massoumi, Hatef
Catana, Andreea M.
Purnak, Tugrul
Rigamonti, Cristina
Aldana, Andres J. G.
Khakoo, Nidah
Nazal, Leyla
Frager, Shalom
Demir, Nurhan
Irak, Kader
Melekoğlu Ellik, Zeynep
Kacmaz, Hüseyin
Balaban, Yasemin
Atay, Kadri
Eren, Fatih
Alvares da-Silva, Mario R.
Cristoferi, Laura
Urzua, Álvaro
Eşkazan, Tuğçe
Magro, Bianca
Snijders, Romee
Barutçu, Sezgin
Lytvyak, Ellina
Zazueta, Godolfino M.
Demirezer Bolat, Aylin
Aydın, Mesut
Amorós Martín, Alexandra Noemí
De Martin, Eleonora
Ekin, Nazım
Yıldırım, Sümeyra
Yavuz, Ahmet
Bıyık, Murat
Narro, Graciela C.
Kıyıcı, Murat
Kahramanoğlu Aksoy, Evrim
Vincent, Maria
Carr, Rotonya M.
Günşar, Fulya
Reyes, Eira C.
Harputluoğlu, Murat
Aloman, Costica
Gatselis, Nikolaos K.
Üstündağ, Yücel
Brahm, Javier
Vargas, Nataly C. E.
Güzelbulut, Fatih
Garcia, Sandro R.
Aguirre, Jonathan
Anders, Margarita
Ratusnu, Natalia
Hatemi, Ibrahim
Mendizabal, Manuel
Floreani, Annarosa
Fagiuoli, Stefano
Silva, Marcelo
Idilman, Ramazan
Satapathy, Sanjaya K.
Silveira, Marina
Drenth, Joost P. H.
Dalekos, George N.
N.Assis, David
Björnsson, Einar
Boyer, James L.
Yoshida, Eric M.
Invernizzi, Pietro
Levy, Cynthia
Montano Loza, Aldo J.
Schiano, Thomas D.
Ridruejo, Ezequiel
Wahlin, Staffan
author_role author
author2 Lammert, Craig
Taşçılar, Koray
Dhanasekaran, Renumathy
Ebik, Berat
Higuera de la Tijera, Fatima
Calışkan, Ali R.
Peralta, Mirta
Gerussi, Alessio
Massoumi, Hatef
Catana, Andreea M.
Purnak, Tugrul
Rigamonti, Cristina
Aldana, Andres J. G.
Khakoo, Nidah
Nazal, Leyla
Frager, Shalom
Demir, Nurhan
Irak, Kader
Melekoğlu Ellik, Zeynep
Kacmaz, Hüseyin
Balaban, Yasemin
Atay, Kadri
Eren, Fatih
Alvares da-Silva, Mario R.
Cristoferi, Laura
Urzua, Álvaro
Eşkazan, Tuğçe
Magro, Bianca
Snijders, Romee
Barutçu, Sezgin
Lytvyak, Ellina
Zazueta, Godolfino M.
Demirezer Bolat, Aylin
Aydın, Mesut
Amorós Martín, Alexandra Noemí
De Martin, Eleonora
Ekin, Nazım
Yıldırım, Sümeyra
Yavuz, Ahmet
Bıyık, Murat
Narro, Graciela C.
Kıyıcı, Murat
Kahramanoğlu Aksoy, Evrim
Vincent, Maria
Carr, Rotonya M.
Günşar, Fulya
Reyes, Eira C.
Harputluoğlu, Murat
Aloman, Costica
Gatselis, Nikolaos K.
Üstündağ, Yücel
Brahm, Javier
Vargas, Nataly C. E.
Güzelbulut, Fatih
Garcia, Sandro R.
Aguirre, Jonathan
Anders, Margarita
Ratusnu, Natalia
Hatemi, Ibrahim
Mendizabal, Manuel
Floreani, Annarosa
Fagiuoli, Stefano
Silva, Marcelo
Idilman, Ramazan
Satapathy, Sanjaya K.
Silveira, Marina
Drenth, Joost P. H.
Dalekos, George N.
N.Assis, David
Björnsson, Einar
Boyer, James L.
Yoshida, Eric M.
Invernizzi, Pietro
Levy, Cynthia
Montano Loza, Aldo J.
Schiano, Thomas D.
Ridruejo, Ezequiel
Wahlin, Staffan
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv AUTOIMMUNITY
AZATHIOPRINE
BUDESONIDE
LIVER TRANSPLANTATION
MERCAPTOPURINE
SARS-COV-2
COVID-19
topic AUTOIMMUNITY
AZATHIOPRINE
BUDESONIDE
LIVER TRANSPLANTATION
MERCAPTOPURINE
SARS-COV-2
COVID-19
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Background: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes of AIH patients who were on immunosuppression at the time of COVID-19 were compared to patients who were not on AIH medication. The clinical courses of COVID-19 were classified as (i)-no hospitalization, (ii)-hospitalization without oxygen supplementation, (iii)-hospitalization with oxygen supplementation by nasal cannula or mask, (iv)-intensive care unit (ICU) admission with non-invasive mechanical ventilation, (v)-ICU admission with invasive mechanical ventilation or (vi)-death and analysed using ordinal logistic regression. Results: We included 254 AIH patients (79.5%, female) with a median age of 50 (range, 17-85) years. At the onset of COVID-19, 234 patients (92.1%) were on treatment with glucocorticoids (n = 156), thiopurines (n = 151), mycophenolate mofetil (n = 22) or tacrolimus (n = 16), alone or in combinations. Overall, 94 (37%) patients were hospitalized and 18 (7.1%) patients died. Use of systemic glucocorticoids (adjusted odds ratio [aOR] 4.73, 95% CI 1.12-25.89) and thiopurines (aOR 4.78, 95% CI 1.33-23.50) for AIH was associated with worse COVID-19 severity, after adjusting for age-sex, comorbidities and presence of cirrhosis. Baseline treatment with mycophenolate mofetil (aOR 3.56, 95% CI 0.76-20.56) and tacrolimus (aOR 4.09, 95% CI 0.69-27.00) were also associated with more severe COVID-19 courses in a smaller subset of treated patients. Conclusion: Baseline treatment with systemic glucocorticoids or thiopurines prior to the onset of COVID-19 was significantly associated with COVID-19 severity in patients with AIH.
Fil: Efe, Cumali. Harran University Hospita; Turquía
Fil: Lammert, Craig. University School of Medicine Indianapolis; Estados Unidos
Fil: Taşçılar, Koray. Universitat Erlangen-Nuremberg; Alemania
Fil: Dhanasekaran, Renumathy. University of Stanford; Estados Unidos
Fil: Ebik, Berat. Gazi Yasargil Education And Research Hospital; Turquía
Fil: Higuera de la Tijera, Fatima. Hospital General de México; México
Fil: Calışkan, Ali R.. No especifíca;
Fil: Peralta, Mirta. Gobierno de la Ciudad de Buenos Aires. Hospital de Infecciosas "Dr. Francisco Javier Muñiz"; Argentina
Fil: Gerussi, Alessio. Università degli Studi di Milano; Italia
Fil: Massoumi, Hatef. No especifíca;
Fil: Catana, Andreea M.. Harvard Medical School; Estados Unidos
Fil: Purnak, Tugrul. University of Texas; Estados Unidos
Fil: Rigamonti, Cristina. Università del Piemonte Orientale ; Italia
Fil: Aldana, Andres J. G.. Fundacion Santa Fe de Bogota; Colombia
Fil: Khakoo, Nidah. Miami University; Estados Unidos
Fil: Nazal, Leyla. Clinica Las Condes; Chile
Fil: Frager, Shalom. Montefiore Medical Center; Estados Unidos
Fil: Demir, Nurhan. Haseki Training And Research Hospital; Turquía
Fil: Irak, Kader. Kanuni Sultan Suleyman Training And Research Hospital; Turquía
Fil: Melekoğlu Ellik, Zeynep. Ankara University Medical Faculty; Turquía
Fil: Kacmaz, Hüseyin. Adıyaman University; Turquía
Fil: Balaban, Yasemin. Hacettepe University; Turquía
Fil: Atay, Kadri. No especifíca;
Fil: Eren, Fatih. No especifíca;
Fil: Alvares da-Silva, Mario R.. Universidade Federal do Rio Grande do Sul; Brasil
Fil: Cristoferi, Laura. Università degli Studi di Milano; Italia
Fil: Urzua, Álvaro. Universidad de Chile; Chile
Fil: Eşkazan, Tuğçe. Cerrahpaşa School of Medicine; Turquía
Fil: Magro, Bianca. No especifíca;
Fil: Snijders, Romee. No especifíca;
Fil: Barutçu, Sezgin. No especifíca;
Fil: Lytvyak, Ellina. University of Alberta; Canadá
Fil: Zazueta, Godolfino M.. Instituto Nacional de la Nutrición Salvador Zubiran; México
Fil: Demirezer Bolat, Aylin. Ankara City Hospital; Turquía
Fil: Aydın, Mesut. Van Yuzuncu Yil University; Turquía
Fil: Amorós Martín, Alexandra Noemí. No especifíca;
Fil: De Martin, Eleonora. No especifíca;
Fil: Ekin, Nazım. No especifíca;
Fil: Yıldırım, Sümeyra. No especifíca;
Fil: Yavuz, Ahmet. No especifíca;
Fil: Bıyık, Murat. Necmettin Erbakan University; Turquía
Fil: Narro, Graciela C.. Instituto Nacional de la Nutrición Salvador Zubiran; México
Fil: Bıyık, Murat. Uludag University; Turquía
Fil: Kıyıcı, Murat. No especifíca;
Fil: Kahramanoğlu Aksoy, Evrim. No especifíca;
Fil: Vincent, Maria. No especifíca;
Fil: Carr, Rotonya M.. University of Pennsylvania; Estados Unidos
Fil: Günşar, Fulya. No especifíca;
Fil: Reyes, Eira C.. Hepatology Unit. Hospital Militar Central de México; México
Fil: Harputluoğlu, Murat. Inönü University School of Medicine; Turquía
Fil: Aloman, Costica. Rush University Medical Center; Estados Unidos
Fil: Gatselis, Nikolaos K.. University Hospital Of Larissa; Grecia
Fil: Üstündağ, Yücel. No especifíca;
Fil: Brahm, Javier. Clinica Las Condes; Chile
Fil: Vargas, Nataly C. E.. Hospital Nacional Almanzor Aguinaga Asenjo; Perú
Fil: Güzelbulut, Fatih. No especifíca;
Fil: Garcia, Sandro R.. Hospital Iv Víctor Lazarte Echegaray; Perú
Fil: Aguirre, Jonathan. Hospital Angeles del Pedregal; México
Fil: Anders, Margarita. Hospital Alemán; Argentina
Fil: Ratusnu, Natalia. Hospital Regional de Ushuaia; Argentina
Fil: Hatemi, Ibrahim. No especifíca;
Fil: Mendizabal, Manuel. Universidad Austral; Argentina
Fil: Floreani, Annarosa. Università di Padova; Italia
Fil: Fagiuoli, Stefano. No especifíca;
Fil: Silva, Marcelo. Universidad Austral; Argentina
Fil: Idilman, Ramazan. No especifíca;
Fil: Satapathy, Sanjaya K.. No especifíca;
Fil: Silveira, Marina. University of Yale. School of Medicine; Estados Unidos
Fil: Drenth, Joost P. H.. No especifíca;
Fil: Dalekos, George N.. No especifíca;
Fil: N.Assis, David. University of Yale. School of Medicine; Estados Unidos
Fil: Björnsson, Einar. No especifíca;
Fil: Boyer, James L.. University of Yale. School of Medicine; Estados Unidos
Fil: Yoshida, Eric M.. University of British Columbia; Canadá
Fil: Invernizzi, Pietro. Università degli Studi di Milano; Italia
Fil: Levy, Cynthia. University of Miami; Estados Unidos
Fil: Montano Loza, Aldo J.. University of Alberta; Canadá
Fil: Schiano, Thomas D.. No especifíca;
Fil: Ridruejo, Ezequiel. Universidad Austral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; Argentina
Fil: Wahlin, Staffan. No especifíca;
description Background: We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods: Data of AIH patients with laboratory confirmed COVID-19 were retrospectively collected from 15 countries. The outcomes of AIH patients who were on immunosuppression at the time of COVID-19 were compared to patients who were not on AIH medication. The clinical courses of COVID-19 were classified as (i)-no hospitalization, (ii)-hospitalization without oxygen supplementation, (iii)-hospitalization with oxygen supplementation by nasal cannula or mask, (iv)-intensive care unit (ICU) admission with non-invasive mechanical ventilation, (v)-ICU admission with invasive mechanical ventilation or (vi)-death and analysed using ordinal logistic regression. Results: We included 254 AIH patients (79.5%, female) with a median age of 50 (range, 17-85) years. At the onset of COVID-19, 234 patients (92.1%) were on treatment with glucocorticoids (n = 156), thiopurines (n = 151), mycophenolate mofetil (n = 22) or tacrolimus (n = 16), alone or in combinations. Overall, 94 (37%) patients were hospitalized and 18 (7.1%) patients died. Use of systemic glucocorticoids (adjusted odds ratio [aOR] 4.73, 95% CI 1.12-25.89) and thiopurines (aOR 4.78, 95% CI 1.33-23.50) for AIH was associated with worse COVID-19 severity, after adjusting for age-sex, comorbidities and presence of cirrhosis. Baseline treatment with mycophenolate mofetil (aOR 3.56, 95% CI 0.76-20.56) and tacrolimus (aOR 4.09, 95% CI 0.69-27.00) were also associated with more severe COVID-19 courses in a smaller subset of treated patients. Conclusion: Baseline treatment with systemic glucocorticoids or thiopurines prior to the onset of COVID-19 was significantly associated with COVID-19 severity in patients with AIH.
publishDate 2021
dc.date.none.fl_str_mv 2021-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/172868
Efe, Cumali; Lammert, Craig; Taşçılar, Koray; Dhanasekaran, Renumathy; Ebik, Berat; et al.; Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis; Wiley Blackwell Publishing, Inc; Liver International; 42; 3; 11-2021; 607-614
1478-3223
CONICET Digital
CONICET
url http://hdl.handle.net/11336/172868
identifier_str_mv Efe, Cumali; Lammert, Craig; Taşçılar, Koray; Dhanasekaran, Renumathy; Ebik, Berat; et al.; Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis; Wiley Blackwell Publishing, Inc; Liver International; 42; 3; 11-2021; 607-614
1478-3223
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1111/liv.15121
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
publisher.none.fl_str_mv Wiley Blackwell Publishing, Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613129083813888
score 13.070432